Dr. Tarek Bismar from the Prostate Cancer Centre joins us again to talk about PARP inhibitors and their role in cancer treatment. He shows their activity in cancer cells, synergy with other cancer therapies, side effects and how people respond to inhibitors depending on their cancer type.